Tachycardia is a heart rate faster than 100 beats per minute at rest. A normal resting heart rate for adults falls between 60 and 100 beats per minute, so tachycardia begins where that upper limit ends. The term covers a broad family of rhythm disturbances, from the completely benign spike you feel after climbing stairs to life-threatening electrical chaos in the ventricles. What makes tachycardia tricky is that the same symptom can signal anything from too much coffee to a pulmonary embolism, and the type of fast rhythm matters as much as the speed itself.
Why a Fast Heart Rate Is Not Always Tachycardia
Your heart rate rises every time you exercise, feel anxious, run a fever, or stand up quickly. That is your sinus node doing its job, responding to normal demands by firing faster. This kind of increase is called physiological sinus tachycardia, and it resolves once the demand passes. It is not a disease. The concern starts when the heart stays fast at rest without an obvious reason, or when the fast rhythm originates from an abnormal electrical pathway altogether.
Even among people whose hearts beat above 100 at rest, the explanation is often a treatable medical condition rather than a primary heart problem. Anemia, infection, dehydration, an overactive thyroid, or a blood clot in the lung can all push the sinus rate up as a secondary effect.1Europe PMC. Sinus Tachycardia: a Multidisciplinary Expert Focused Review In those cases, the tachycardia itself is a symptom, not the root problem, and treating the underlying cause brings the heart rate down.
The Major Types
Cardiologists sort tachycardias by where in the heart the abnormal electrical signal starts. That distinction matters because it determines how dangerous the rhythm is and which treatments work.
Sinus Tachycardia
When the heart’s natural pacemaker, the sinus node, fires too fast at rest without an identifiable medical trigger, the condition is called inappropriate sinus tachycardia (IST). People with IST have resting heart rates above 100 and often experience palpitations, lightheadedness, and shortness of breath. The cause is not fully understood, but current thinking points to either an intrinsically overactive sinus node or external factors, including antibodies that stimulate the heart’s beta-adrenergic receptors.2PubMed Central. Challenges in Treatment of Inappropriate Sinus Tachycardia IST is more common in young women and is often misdiagnosed as anxiety. It is rarely dangerous, but it can be debilitating.
Supraventricular Tachycardia
Supraventricular tachycardia, or SVT, is an umbrella term for fast rhythms that originate above the ventricles. The most common forms involve reentrant circuits, meaning the electrical signal gets caught in a loop rather than traveling its normal one-way path. In atrioventricular nodal reentrant tachycardia (AVNRT), the loop circles within or near the AV node. In atrioventricular reentrant tachycardia (AVRT), the loop uses an extra electrical connection between the atria and ventricles, sometimes associated with Wolff-Parkinson-White syndrome. AVRT in its more common form is inducible in roughly 55 percent of people with that extra pathway.3PubMed Central. Antidromic Atrioventricular Reentry Tachycardia with Wolff Parkinson White Syndrome: A Rare Beast
Atrial fibrillation and atrial flutter also fall under the supraventricular category. In atrial fibrillation, the atria fire chaotically at rates of 300 to 600 impulses per minute, with only a fraction of those impulses reaching the ventricles. Atrial flutter is more organized, with the atria beating at roughly 250 to 350 beats per minute in a sawtooth pattern. Both can drive a fast ventricular rate and carry risks of their own, including stroke and heart failure.
Ventricular Tachycardia
Ventricular tachycardia (VT) originates in the lower chambers and is the type that keeps emergency physicians on edge. When the ventricles fire rapidly on their own, they may not fill with enough blood between beats to maintain adequate circulation. Sustained VT can degenerate into ventricular fibrillation, where the heart quivers uselessly and cardiac arrest follows within minutes. The underlying mechanism often involves abnormal calcium handling inside heart muscle cells. When calcium leaks from internal stores during the resting phase of the heartbeat, it can trigger extra electrical impulses that propagate through the ventricles and set off a rapid, unstable rhythm.4JCI Insight. Mechanisms of sudden cardiac death Scarring from a previous heart attack is one of the most common structural causes of VT, because scar tissue creates zones where electrical signals slow down and loop back on themselves.
Postural Tachycardia Syndrome
POTS deserves its own discussion because it is increasingly recognized, frequently misunderstood, and not a single disease so much as a cluster of overlapping problems. People with POTS experience a heart rate jump of 30 beats per minute or more within minutes of standing up, without a corresponding drop in blood pressure.5PubMed Central. The Postural Tachycardia Syndrome (POTS): pathophysiology, diagnosis & management The tachycardia is the body’s compensation for blood pooling in the legs and abdomen when the nerves that normally squeeze those blood vessels back toward the heart are not working properly.6Current Problems in Cardiology. Pathophysiology and management of postural orthostatic tachycardia syndrome (POTS): A literature review
The underlying drivers of POTS include partial autonomic neuropathy, low blood volume, elevated resting sympathetic tone, mast cell activation, physical deconditioning, and in some cases autoantibodies.7PubMed Central. Postural Tachycardia Syndrome: Beyond Orthostatic Intolerance It gained wider public attention during the wave of post-COVID dysautonomia cases, but it existed long before the pandemic and has been described in the medical literature for decades. Most patients are young women, and many cycle through years of misdiagnosis before landing on the correct one.
Triggers Beyond the Heart
Many episodes of tachycardia start not with a wiring defect in the heart but with something happening elsewhere in the body.
An overactive thyroid gland floods the body with hormones that rev up metabolism and directly stimulate the heart. In severe cases, known as thyroid storm, the cardiovascular system can decompensate, producing dangerously fast heart rates alongside fever, agitation, and organ dysfunction.8PubMed Central. Thyroid emergencies
Electrolyte imbalances, particularly low potassium, are a well-documented arrhythmia trigger. Potassium is essential for regulating the electrical excitability of heart cells, and when levels drop, the heart becomes more vulnerable to abnormal rhythms.9PubMed Central. Hypokalemia-Induced Arrhythmia: A Case Series and Literature Review In one study of patients presenting with ventricular tachycardia or ventricular fibrillation, over a third had low potassium, compared with about 13 percent of patients with heart failure alone.10PubMed. Electrolyte Abnormalities in Patients Presenting With Ventricular Arrhythmia (from the LYTE-VT Study) Diuretics, heavy sweating, vomiting, and poor diet are all common routes to potassium depletion.
Stimulant drugs are another major trigger. Cocaine and methamphetamine alter the heart’s electrical system through multiple pathways, changing how ion channels behave and promoting both atrial and ventricular fast rhythms.11PubMed Central. Stimulant Drugs of Abuse and Cardiac Arrhythmias Caffeine, at normal dietary doses, is generally considered safe for the heart. However, caffeine acts on the same calcium-release channels involved in ventricular arrhythmias, and in cases of extreme overdose it has triggered serious rhythm disturbances through that mechanism.12PubMed. Bidirectional ventricular tachycardia induced by caffeine poisoning The practical takeaway is that a couple of cups of coffee are unlikely to cause a dangerous rhythm, but caffeine pills, energy-drink binges, or pre-workout supplements at high doses are a different story.
How Tachycardia Gets Diagnosed
A standard 12-lead electrocardiogram (ECG) is the first tool. If you are having a fast rhythm at the moment the ECG is recorded, the tracing often reveals the type of tachycardia and where it originates. The problem is that many arrhythmias come and go. You might feel your heart racing at 3 a.m. and have a perfectly normal tracing by the time you reach the clinic.
For intermittent episodes, longer-term monitoring fills the gap. The traditional Holter monitor records continuously for 24 to 48 hours, but wearable patch monitors that record for up to two weeks detect arrhythmias at significantly higher rates. In one comparison, patch monitors caught major arrhythmias in about 76 percent of patients versus 48 percent for Holter monitors, with the gap driven by events that occurred after the first day of recording.13PubMed Central. A Patch-Type Electrocardiography Is Superior to Holter Monitoring for Detecting Paroxysmal Cardiac Arrhythmias For even rarer events, implantable loop recorders can monitor continuously for years.
Wearable consumer devices have entered the picture too. A meta-analysis of smartwatch studies found that these devices detect atrial fibrillation with about 95 percent sensitivity and 97 percent specificity, with comparable accuracy across different brands and sensor technologies.14PubMed Central. Accuracy of Smartwatches in the Detection of Atrial Fibrillation: A Systematic Review and Diagnostic Meta-Analysis That is good enough to be a useful screening flag, though not a replacement for clinical-grade recording when a definitive diagnosis is needed. Remote and wearable ECG devices show strong potential for long-term monitoring, particularly when paired with real-time alert features.15PubMed Central. Remote and wearable ECG devices with diagnostic abilities in adults: A state-of-the-science scoping review
Some arrhythmias require provocation to be caught. Catecholaminergic polymorphic ventricular tachycardia, a rare genetic condition, tends to produce dangerous rhythms only during exercise or emotional stress. Standard Holter monitoring misses it because the abnormal beats concentrate during periods of high heart rate. One study found that analyzing premature beats specifically during periods when heart rate exceeded 76 percent of the patient’s maximum identified the condition with high specificity.16PubMed. The Diagnostic Utility of Holter Monitoring in Catecholaminergic Polymorphic Ventricular Tachycardia For most patients suspected of exercise-triggered arrhythmias, a treadmill stress test is the standard diagnostic step.
First-Line Treatment and Vagal Maneuvers
If you feel a sudden onset of rapid, regular pounding in your chest, the first thing to try, before any medication, is a vagal maneuver. The Valsalva maneuver (bearing down as if straining during a bowel movement) increases pressure inside the chest, which stimulates the vagus nerve and temporarily slows conduction through the AV node. This can break the reentrant loop responsible for SVT.17Cochrane Database of Systematic Reviews. Valsalva Manoeuvre versus other vagal manoeuvres and paced retrograde conduction for supraventricular tachycardia Other techniques include plunging your face into ice water, coughing forcefully, or applying gentle pressure to the carotid sinus in the neck (though that last one carries risks and is better left to medical professionals).
Vagal maneuvers work best for AVRT and AVNRT, the two most common reentrant SVTs. In a study of AVRT patients, the Valsalva maneuver terminated the tachycardia in about half the cases, with the success depending on both the patient’s vagal tone and the electrical properties of the reentrant circuit.18PubMed. Electrophysiological mechanisms and determinants of vagal maneuvers for termination of paroxysmal supraventricular tachycardia When vagal maneuvers fail, intravenous adenosine is the standard emergency-room drug for SVT. It briefly blocks AV node conduction, breaking the circuit. The sensation is unpleasant, a few seconds of chest pressure and a feeling that the heart has stopped, but the drug clears the system within seconds.
Medications for Ongoing Management
Antiarrhythmic drugs are organized by their primary mechanism of action. The framework cardiologists use groups them into classes based on which ion channels or receptors they target, though in practice many drugs affect more than one channel.19PubMed. Modernized Classification of Cardiac Antiarrhythmic Drugs
For most people with recurrent SVT or IST, beta-blockers are the first medication tried. They work by dampening the effect of adrenaline on the heart, slowing the rate and reducing the force of contraction.20PubMed. Classification and mechanism of action of antiarrhythmic drugs Calcium channel blockers like verapamil and diltiazem are an alternative when beta-blockers are not tolerated. For ventricular tachycardia, amiodarone is often the go-to drug, though it comes with a long list of potential side effects affecting the thyroid, lungs, liver, and skin with extended use. The choice of drug always involves balancing the risk of the arrhythmia against the side effects of the medication, and for many people with infrequent, well-tolerated SVT episodes, no daily medication is needed at all.
Catheter Ablation
When medication is not enough, or when a patient prefers a more definitive fix, catheter ablation is often the answer. A thin catheter is threaded through a vein into the heart, and the tissue responsible for the abnormal electrical signal is destroyed using either heat (radiofrequency energy) or extreme cold (cryoablation). For AVNRT, both methods achieve acute success rates above 95 percent.21PubMed. Cryoablation versus radiofrequency energy for the ablation of atrioventricular nodal reentrant tachycardia (the CYRANO Study): results from a large multicenter prospective randomized trial
The main trade-off between the two techniques is recurrence risk versus complication risk. In a large multicenter trial, immediate success rates were nearly identical, but AVNRT came back about twice as often after cryoablation compared to radiofrequency ablation. On the other hand, cryoablation had a lower risk of causing permanent damage to the AV node, a complication that would require a permanent pacemaker.22European Heart Journal. CRAVT: a prospective, randomized study comparing transvenous cryothermal and radiofrequency ablation in atrioventricular nodal re-entrant tachycardia 23PubMed. Cryoablation versus radiofrequency ablation for the treatment of atrioventricular nodal reentrant tachycardia: results of a prospective randomized study That makes cryoablation attractive for younger patients or those whose abnormal circuit sits very close to the normal conduction system.
For ventricular tachycardia, ablation is more complex. The catheter maps the scar tissue and abnormal pathways, then targets the critical channel sustaining the arrhythmia. Success rates depend heavily on the underlying heart disease, and some patients need more than one procedure.
Implantable Devices for Dangerous Rhythms
When ventricular tachycardia or ventricular fibrillation poses a persistent threat and medication or ablation cannot reliably prevent episodes, an implantable cardioverter-defibrillator (ICD) serves as a safety net. The device continuously monitors the heart’s rhythm and delivers a shock if it detects a lethal arrhythmia. Traditional ICDs use leads threaded through veins into the heart itself, but entirely subcutaneous models that sit under the skin outside the ribcage have been developed. In early studies, subcutaneous ICDs successfully detected and treated all episodes of spontaneous sustained ventricular tachyarrhythmia.24PubMed. An entirely subcutaneous implantable cardioverter-defibrillator The subcutaneous approach avoids the risks associated with placing leads inside the heart, such as infection and lead fracture, though it cannot deliver anti-tachycardia pacing, a gentler intervention that traditional ICDs use to overdrive-pace a VT episode back to normal rhythm before resorting to a shock.
When Tachycardia Damages the Heart
A heart that beats too fast for too long can weaken. Tachycardia-induced cardiomyopathy is the term for heart muscle deterioration caused by sustained rapid rates, and it is one of the strongest arguments for treating even “benign” arrhythmias like chronic atrial fibrillation or atrial flutter. In a study of patients whose cardiomyopathy was traced to uncontrolled tachycardia, heart function improved or normalized in all patients within six months of getting the rate or rhythm under control.25PubMed. Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia The reversibility is the good news. The bad news is that when the arrhythmia returned in those same patients, heart function dropped rapidly, within months rather than the years it had taken to decline initially.
Atrial fibrillation is the most common culprit. Beyond weakening the heart muscle through sheer speed, it also reduces cardiac output by eliminating the atria’s coordinated contribution to filling the ventricles.26JACC: Clinical Electrophysiology. Risks of Heart Failure, Stroke, and Bleeding in Atrial Fibrillation According to Heart Failure Phenotypes This is why rate control or rhythm restoration in atrial fibrillation is not just about relieving symptoms; it protects the heart’s long-term pumping ability.
Tachycardia During Pregnancy
Pregnancy increases resting heart rate by 10 to 20 beats per minute as blood volume expands and cardiac output rises to supply the growing fetus. That physiological increase means a pregnant person’s “normal” resting rate might sit in the 90s, making it harder to recognize when tachycardia crosses into pathological territory.27PubMed Central. Tachycardia in pregnancy: when to worry? New-onset SVT during pregnancy does happen, sometimes triggered by the hormonal and hemodynamic changes themselves.
Treatment follows the same general principles as in non-pregnant patients, but drug choices are constrained by fetal safety. Beta-blockers are generally considered acceptable, while certain antiarrhythmics are avoided due to the risk of birth defects. When drug treatment fails or the patient is hemodynamically unstable, electrical cardioversion can be used and is considered safe at all stages of pregnancy, though the fetus should be monitored during and after the procedure.28PubMed. Maternal arrhythmias during pregnancy Catheter ablation is typically deferred until after delivery unless the arrhythmia is refractory and dangerous, because it requires fluoroscopy (X-ray exposure) and carries procedural risks.
How Electrophysiology Became a Specialty
The ability to diagnose and treat arrhythmias from inside the heart is relatively young. The first recording of the His bundle, the electrical highway connecting the atria and ventricles, was accomplished in 1969. Through the 1970s, physicians developed techniques to provoke arrhythmias in the electrophysiology lab, figure out their circuits, and test whether drugs could suppress them. By the 1980s, those same mapping techniques were guiding surgeons to cut out the tissue causing the arrhythmia.29PubMed. Evolution of diagnostic and interventional cardiac electrophysiology: a brief historical review Catheter ablation replaced most of those open-heart surgeries in the 1990s, and the field has continued to evolve with three-dimensional mapping systems, robotic catheter navigation, and increasingly sophisticated implantable devices. What used to require cracking the chest open can now be done through a puncture in the groin, often as a same-day procedure.